We are an independent company, with more than 3 decades of experience in marketing healthcare products. The company is privately held by the founders. With its roots in haemodialysis, Dirinco has become an expert in extracorporeal circulation treatment of renal failure and catheter lock solutions.
Today the company holds a good position in the healthcare market, focusing on the areas of nephrology (e.g. hemodialysis) and intensive care (e.g. hemofiltration and sepsis). We have strong business relationships with management, pharmacies and purchase departments of hospital organizations.
We have a direct sales and service organization for the Benelux and offer our innovations through a network of dedicated distributors to the remaining international markets.
Building on the innovative legacy and our highly esteemed reputation, we have recently entered a new phase in moving the organization forward. On the one side focussing on international business development by leveraging the development of Dirinco’s own portfolio, and on the other, a new management and sales–marketing structure has been introduced to strengthen the process of best developing our franchises in the targeted areas.
Our customers value us for:
Being an independent, targeted organization, our mission is to continue to meet these customer values by offering an innovative portfolio, marketed by a highly motivated and professional team.
We are open to explore collaborations with business partners interested in joining us to achieve our ambition to deliver innovative products designed to meet the best interests of all stakeholders.
For more information on our companys and products please visit:
More efficient than Taurolidine-based Locking Solutions to prevent Thrombotic Dysfunction of Tunnelled Hemodialyse Catheters: a Retrospective Cohort Study.
We are an independent company, with more than three decades of experience in marketing healthcare products.
With its roots in haemodialysis, Dirinco has become an expert in extracorporeal circulation treatment of renal failure and catheter lock solutions.